CH597175A5 - - Google Patents

Info

Publication number
CH597175A5
CH597175A5 CH1386573A CH1386573A CH597175A5 CH 597175 A5 CH597175 A5 CH 597175A5 CH 1386573 A CH1386573 A CH 1386573A CH 1386573 A CH1386573 A CH 1386573A CH 597175 A5 CH597175 A5 CH 597175A5
Authority
CH
Switzerland
Application number
CH1386573A
Inventor
Jean Bowler
Keith Blakeney Mallion
Dora Nellie Richardson
Edward Douglas Brown
Peter Robert Marsham
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of CH597175A5 publication Critical patent/CH597175A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Quinoline Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH1386573A 1972-09-27 1973-09-27 CH597175A5 (US08124317-20120228-C00018.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4465272A GB1428137A (en) 1972-09-27 1972-09-27 Prostanoic acid derivatives

Publications (1)

Publication Number Publication Date
CH597175A5 true CH597175A5 (US08124317-20120228-C00018.png) 1978-03-31

Family

ID=10434217

Family Applications (3)

Application Number Title Priority Date Filing Date
CH1363176A CH596164A5 (US08124317-20120228-C00018.png) 1972-09-27 1973-09-27
CH1363276A CH595341A5 (US08124317-20120228-C00018.png) 1972-09-27 1973-09-27
CH1386573A CH597175A5 (US08124317-20120228-C00018.png) 1972-09-27 1973-09-27

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CH1363176A CH596164A5 (US08124317-20120228-C00018.png) 1972-09-27 1973-09-27
CH1363276A CH595341A5 (US08124317-20120228-C00018.png) 1972-09-27 1973-09-27

Country Status (25)

Country Link
US (1) US3931206A (US08124317-20120228-C00018.png)
JP (1) JPS49100071A (US08124317-20120228-C00018.png)
AR (1) AR207550A1 (US08124317-20120228-C00018.png)
AT (1) AT340610B (US08124317-20120228-C00018.png)
BE (1) BE805358A (US08124317-20120228-C00018.png)
CA (1) CA1037033A (US08124317-20120228-C00018.png)
CH (3) CH596164A5 (US08124317-20120228-C00018.png)
CS (3) CS178895B2 (US08124317-20120228-C00018.png)
DD (1) DD107899A5 (US08124317-20120228-C00018.png)
DE (1) DE2348632A1 (US08124317-20120228-C00018.png)
EG (1) EG11278A (US08124317-20120228-C00018.png)
ES (5) ES419143A1 (US08124317-20120228-C00018.png)
FR (1) FR2200014B1 (US08124317-20120228-C00018.png)
GB (1) GB1428137A (US08124317-20120228-C00018.png)
HU (1) HU171777B (US08124317-20120228-C00018.png)
IE (1) IE38241B1 (US08124317-20120228-C00018.png)
IL (1) IL43248A (US08124317-20120228-C00018.png)
NL (1) NL7313322A (US08124317-20120228-C00018.png)
NO (1) NO145380C (US08124317-20120228-C00018.png)
PL (2) PL96782B1 (US08124317-20120228-C00018.png)
SE (3) SE424859B (US08124317-20120228-C00018.png)
SU (1) SU648088A3 (US08124317-20120228-C00018.png)
YU (2) YU254573A (US08124317-20120228-C00018.png)
ZA (1) ZA737357B (US08124317-20120228-C00018.png)
ZM (1) ZM15873A1 (US08124317-20120228-C00018.png)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953502A (en) 1973-01-31 1976-04-27 Imperial Chemical Industries Limited Cyclopentane derivatives
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
GB1507211A (en) * 1975-02-14 1978-04-12 Ono Pharmaceutical Co Prostaglandin analogues
DE2524955C3 (de) * 1975-06-05 1981-12-03 Hoechst Ag, 6000 Frankfurt Neue Thienyl-Prostaglandine und Verfahren zu ihrer Herstellung
US4464532A (en) * 1979-07-31 1984-08-07 Nippon Kayaku Kabushiki Kaisha Intermediates of 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazone
US5545665A (en) 1993-12-28 1996-08-13 Allergan Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
AU6452098A (en) 1997-03-07 1998-09-22 Metabasis Therapeutics, Inc. Novel purine inhibitors of fructose-1,6-bisphosphatase
DE69819311T2 (de) 1997-03-07 2004-07-29 Metabasis Therapeutics Inc., San Diego Neue benzimidazol inhibitoren der fructose-1,6-bisphosphatase
AU6691798A (en) 1997-03-07 1998-09-22 Metabasis Therapeutics, Inc. Novel indole and azaindole inhibitors of fructose-1,6-bisphosphatase
HUP0103143A3 (en) * 1998-09-09 2003-01-28 Metabasis Therapeutics Inc San Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase, process for their preparation and their use
EP1159266B1 (en) * 1999-03-05 2004-11-03 Duke University C-16 unsaturated fp-selective prostaglandins analogs
CN100595204C (zh) * 1999-12-22 2010-03-24 症变治疗公司 双氨基化膦酸酯前药
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US7563774B2 (en) * 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
EP1778250A2 (en) * 2004-08-18 2007-05-02 Metabasis Therapeutics, Inc. Novel thiazole inhibitors of fructose 1,6-bisphosphatase
CN113912539B (zh) * 2021-12-13 2022-03-11 山东国邦药业有限公司 一种环丙羧酸的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836578A (en) * 1965-12-16 1974-09-17 Kemiska Inst Prostanoic acid derivatives
US3726909A (en) * 1970-10-16 1973-04-10 P Beal 9,15-dihydroxy prostanoic acids and esters thereof

Also Published As

Publication number Publication date
IE38241B1 (en) 1978-02-01
AT340610B (de) 1977-12-27
CS178895B2 (en) 1977-10-31
GB1428137A (en) 1976-03-17
IE38241L (en) 1975-03-12
CA1037033A (en) 1978-08-22
DD107899A5 (US08124317-20120228-C00018.png) 1974-08-20
SE7611316L (sv) 1976-10-12
JPS49100071A (US08124317-20120228-C00018.png) 1974-09-20
SE424859B (sv) 1982-08-16
DE2348632A1 (de) 1974-04-11
ZA737357B (en) 1974-08-28
SE7611315L (sv) 1976-10-12
IL43248A0 (en) 1973-11-28
EG11278A (en) 1977-08-15
ATA832673A (de) 1977-04-15
ES444046A1 (es) 1977-04-16
NO145380C (no) 1982-03-10
YU254573A (en) 1982-02-28
ES444047A1 (es) 1977-04-16
FR2200014A1 (US08124317-20120228-C00018.png) 1974-04-19
ES444045A1 (es) 1977-04-16
CH595341A5 (US08124317-20120228-C00018.png) 1978-02-15
BE805358A (fr) 1974-03-26
CS178894B2 (en) 1977-10-31
AR207550A1 (es) 1976-10-15
PL96782B1 (pl) 1978-01-31
ES444044A1 (es) 1977-04-16
YU268580A (en) 1983-01-21
FR2200014B1 (US08124317-20120228-C00018.png) 1978-01-13
ES419143A1 (es) 1976-06-16
PL97363B1 (pl) 1978-02-28
HU171777B (hu) 1978-03-28
IL43248A (en) 1977-08-31
SU648088A3 (ru) 1979-02-15
ZM15873A1 (en) 1975-05-21
CS178893B2 (en) 1977-10-31
NO145380B (no) 1981-11-30
NL7313322A (US08124317-20120228-C00018.png) 1974-03-29
CH596164A5 (US08124317-20120228-C00018.png) 1978-02-28
US3931206A (en) 1976-01-06

Similar Documents

Publication Publication Date Title
FR2200014B1 (US08124317-20120228-C00018.png)
CS152699B1 (US08124317-20120228-C00018.png)
BR7310191D0 (US08124317-20120228-C00018.png)
CS152731B1 (US08124317-20120228-C00018.png)
CS152691B1 (US08124317-20120228-C00018.png)
CS157227B1 (US08124317-20120228-C00018.png)
CS156973B1 (US08124317-20120228-C00018.png)
CS156584B1 (US08124317-20120228-C00018.png)
CS156323B1 (US08124317-20120228-C00018.png)
CS155584B1 (US08124317-20120228-C00018.png)
CS155000B1 (US08124317-20120228-C00018.png)
CS154828B1 (US08124317-20120228-C00018.png)
CH569920A5 (US08124317-20120228-C00018.png)
CH580559A5 (US08124317-20120228-C00018.png)
CH559550A5 (US08124317-20120228-C00018.png)
CH559598A5 (US08124317-20120228-C00018.png)
CH559993A5 (US08124317-20120228-C00018.png)
CH560870A5 (US08124317-20120228-C00018.png)
CH562334A5 (US08124317-20120228-C00018.png)
CH565246A5 (US08124317-20120228-C00018.png)
CH565301A5 (US08124317-20120228-C00018.png)
CH566566A5 (US08124317-20120228-C00018.png)
CH569171A5 (US08124317-20120228-C00018.png)
CH249173A4 (US08124317-20120228-C00018.png)
CH570484B5 (US08124317-20120228-C00018.png)

Legal Events

Date Code Title Description
PL Patent ceased